×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by TRUEX PAUL F

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
MISTMilestone Pharmaceuticals Inc.TRUEX PAUL FDirectorMay 31, 2022Buy$1.7681,780143,79581,780Jun 01, 2022, 09:32 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FDirectorSep 07, 2017Buy$1.345,0006,70016,793Sep 07, 2017, 06:56 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FChief Executive OfficerSep 20, 2016Option Exercise$2.085,00810,4175,008Sep 22, 2016, 07:29 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOJun 30, 2014Option Exercise$2.422,6996,53014,709Jul 01, 2014, 08:09 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOJun 30, 2013Option Exercise$3.306,25020,62580,190Mar 28, 2014, 09:23 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOMar 25, 2014Option Exercise$3.308,97429,61411,845Mar 28, 2014, 09:23 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOMar 25, 2014Option Exercise$3.307,62225,1539,333Mar 27, 2014, 09:56 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOMar 25, 2014Option Exercise$3.306,25020,625597,787Mar 27, 2014, 09:56 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOJan 03, 2013Option Exercise$0.6917,45412,04366,412Jan 08, 2013, 05:29 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOJun 29, 2012Buy$0.7620,00015,200645,125Jul 02, 2012, 03:53 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and C.E.O.Feb 15, 2012Sale$7.8415,000117,600625,125Feb 17, 2012, 05:15 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and C.E.O.Jan 31, 2012Option Exercise$0.2620,0005,200640,125Feb 02, 2012, 07:37 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and Chief ExecutiveJan 17, 2012Sale$6.7515,000101,250627,125Jan 19, 2012, 05:03 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEODec 15, 2011Sale$6.3415,00095,065642,125Dec 16, 2011, 09:53 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEONov 15, 2011Sale$6.9630,000208,704672,125Nov 17, 2011, 04:01 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOOct 21, 2011Sale$6.2523,235145,219649,004Oct 25, 2011, 09:55 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOOct 18, 2011Sale$6.256,74542,156660,360Oct 20, 2011, 09:28 PM
TSRXTrius Therapeutics IncTRUEX PAUL FDirectorAug 29, 2011Buy$6.802,00013,60013,270Aug 31, 2011, 08:02 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOAug 08, 2011Option Exercise$0.2650,00013,00090,512Aug 09, 2011, 06:16 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOJul 15, 2011Sale$7.9515,000119,258667,125Jul 18, 2011, 05:40 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOJun 30, 2011Option Exercise$8.1748,500396,24540,512Jul 05, 2011, 06:37 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOJun 15, 2011Sale$8.3015,000124,539682,125Jun 17, 2011, 07:50 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOMay 16, 2011Sale$7.1615,000107,339692,003May 18, 2011, 07:28 PM
ANTHAnthera Pharmaceuticals IncTRUEX PAUL FPresident and CEOApr 13, 2011Option Exercise$0.2630,0007,800121,122Apr 14, 2011, 08:35 PM
TSRXTrius Therapeutics IncTRUEX PAUL FDirectorNov 23, 2010Buy$1.558,36413,00011,270Nov 24, 2010, 12:36 PM